Ilan Theurillat, Ivo A Hendriks, Jack-Christophe Cossec, Alexandra Andrieux, Michael L Nielsen, Anne Dejean
Cell reports 2020 Sep 15Post-translational modification by SUMO is a key regulator of cell identity. In mouse embryonic fibroblasts (MEFs), SUMO impedes reprogramming to pluripotency, while in embryonic stem cells (ESCs), it represses the emergence of totipotent-like cells, suggesting that SUMO targets distinct substrates to preserve somatic and pluripotent states. Using MS-based proteomics, we show that the composition of endogenous SUMOylomes differs dramatically between MEFs and ESCs. In MEFs, SUMO2/3 targets proteins associated with canonical SUMO functions, such as splicing, and transcriptional regulators driving somatic enhancer selection. In contrast, in ESCs, SUMO2/3 primarily modifies highly interconnected repressive chromatin complexes, thereby preventing chromatin opening and transitioning to totipotent-like states. We also characterize several SUMO-modified pluripotency factors and show that SUMOylation of Dppa2 and Dppa4 impedes the conversion to 2-cell-embryo-like states. Altogether, we propose that rewiring the repertoire of SUMO target networks is a major driver of cell fate decision during embryonic development. Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.
Ilan Theurillat, Ivo A Hendriks, Jack-Christophe Cossec, Alexandra Andrieux, Michael L Nielsen, Anne Dejean. Extensive SUMO Modification of Repressive Chromatin Factors Distinguishes Pluripotent from Somatic Cells. Cell reports. 2020 Sep 15;32(11):108146
PMID: 32937131
View Full Text